Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

Q: What does CUSIP 15673T100 represent in this 13F holders report?

CUSIP 15673T100 is the security identifier for IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2023?

62 institutional investors reported IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 15673T100

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 87,670,044
Total 13F shares: 19,290,007
Share change: -725,966
Total reported value: $60,957,915
Put/Call ratio: 7.1%
Price per share: $3.16
Number of holders: 62
Value change: -$2,350,461
Number of buys: 23
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 15673T100?
CUSIP 15673T100 identifies IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 15673T100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAYER AKTIENGESELLSCHAFT	3/4/5	10%+ Owner	— class O/S missing	12,675,838	$18,886,999	—	22 Jun 2021	3/4/5
FMR LLC	13F	Company	6.1%	5,342,983	$18,540,151	—	31 Mar 2023	13F
Versant Venture Capital VI, L.P.	3/4/5	10%+ Owner	— class O/S missing	12,166,109	$18,127,503	—	09 Aug 2022	3/4/5
Casdin Capital, LLC	13F	Company	3.7%	3,206,380	$11,126,139	—	31 Mar 2023	13F
FUJIFILM Cellular Dynamics, Inc.	3/4/5	10%+ Owner	— class O/S missing	6,955,207	$10,363,258	—	22 Jun 2021	3/4/5
BlackRock Finance, Inc.	13F	Company	1.6%	1,411,449	$4,897,728	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	1.5%	1,307,407	$4,536,702	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	1.4%	1,268,100	$4,400,307	—	31 Mar 2023	13F
FEDERATED HERMES, INC.	13F	Company	1.3%	1,164,611	$4,041,200	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	1.3%	1,149,340	$3,988,210	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	1.3%	1,111,069	$3,855,409	—	31 Mar 2023	13F
Deep Track Capital, LP	13F	Company	1.2%	1,022,892	$3,549,435	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.48%	421,177	$1,461,484	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.42%	368,851	$1,279,913	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.37%	322,492	$1,119,047	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.19%	162,673	$564,475	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.17%	153,101	$531,000	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.17%	151,787	$526,701	—	31 Mar 2023	13F
NEW YORK LIFE INVESTMENT MANAGEMENT LLC	13F	Company	0.15%	133,829	$464,387	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	0.13%	110,316	$382,797	—	31 Mar 2023	13F
Luis Borges	3/4/5	Chief Scientific Officer	— class O/S missing	256,535	$382,237	—	03 Apr 2023	3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	0.09%	75,554	$262,000	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	71,289	$247,373	—	31 Mar 2023	13F
Squarepoint Ops LLC	13F	Company	0.08%	67,102	$232,844	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.07%	65,752	$228,000	—	31 Mar 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.07%	61,512	$212,000	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.07%	59,973	$208,106	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.07%	58,952	$205,000	—	31 Mar 2023	13F
Trexquant Investment LP	13F	Company	0.06%	53,891	$187,002	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	52,968	$183,799	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.06%	52,336	$181,606	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.06%	52,200	$181,134	—	31 Mar 2023	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.06%	52,175	$181,047	—	31 Mar 2023	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.06%	49,151	$170,554	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.05%	39,453	$136,902	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.04%	37,218	$129,146	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	31,102	$108,000	—	31 Mar 2023	13F
XTX Topco Ltd	13F	Company	0.04%	30,862	$107,091	—	31 Mar 2023	13F
HARBOURVEST PARTNERS LLC	13F	Company	0.03%	29,018	$100,692	—	31 Mar 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.03%	28,100	$97,507	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.03%	28,100	$97,507	—	31 Mar 2023	13F
Parametrica Management Ltd	13F	Company	0.03%	27,840	$96,605	—	31 Mar 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	19,675	$68,272	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.02%	18,625	$64,629	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	14,482	$50,253	—	31 Mar 2023	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.01%	12,585	$43,670	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	12,460	$43,236	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	10,800	$37,476	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	10,747	$37,292	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.01%	10,285	$35,689	—	31 Mar 2023	13F

Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q2 2023

As of 30 Jun 2023, Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,290,007 shares. The largest 10 holders included FMR LLC, Casdin Capital, LLC, BlackRock Inc., DAFNA Capital Management LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Avidity Partners Management LP, Deep Track Capital, LP, FEDERATED HERMES, INC., and STATE STREET CORP. This page lists 62 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

-1

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.